ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 181 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $833 | +189.2% | 6,108 | +221.0% | 0.01% | +400.0% |
| Q1 2024 | $288 | -94.2% | 1,903 | -95.9% | 0.00% | -98.3% |
| Q1 2023 | $4,969 | +94.4% | 46,347 | +121.4% | 0.06% | +87.1% |
| Q4 2022 | $2,556 | -97.7% | 20,930 | +1816.7% | 0.03% | +3000.0% |
| Q3 2022 | $113,000 | +1.8% | 1,092 | +15.9% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | +2.8% | 942 | +17.8% | 0.00% | 0.0% |
| Q4 2021 | $108,000 | -79.2% | 800 | -75.4% | 0.00% | -50.0% |
| Q3 2021 | $519,000 | +56.3% | 3,254 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $332,000 | +0.9% | 2,527 | +28.2% | 0.00% | 0.0% |
| Q4 2020 | $329,000 | +82.8% | 1,971 | +68.9% | 0.00% | +100.0% |
| Q3 2020 | $180,000 | -27.7% | 1,167 | -47.3% | 0.00% | -50.0% |
| Q1 2020 | $249,000 | -54.9% | 2,213 | -44.3% | 0.00% | -60.0% |
| Q4 2019 | $552,000 | -43.5% | 3,971 | -60.9% | 0.01% | -37.5% |
| Q3 2019 | $977,000 | -34.9% | 10,146 | -22.1% | 0.01% | -20.0% |
| Q2 2019 | $1,500,000 | +509.8% | 13,027 | +523.9% | 0.01% | +400.0% |
| Q1 2019 | $246,000 | +112.1% | 2,088 | +12.6% | 0.00% | +100.0% |
| Q4 2018 | $116,000 | -84.8% | 1,854 | -83.8% | 0.00% | -85.7% |
| Q2 2018 | $762,000 | – | 11,461 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |